ThinkBio.Ai® Joins Mayo Clinic Platform Accelerate June 2026 Cohort

ThinkBio.Ai®, a knowledge-driven AI company focused on transforming complex biological and clinical data into actionable insights, is proud to announce its participation in the Mayo Clinic Platform Accelerate June 2026 Cohort.

Representing ThinkBio.Ai® in the program, Apurva Kalia and John Rakesh participated in the cohort, engaging with Mayo Clinic Platform experts, healthcare innovators, and members of the broader healthcare technology ecosystem.

The program provided ThinkBio.Ai® with an opportunity to explore and refine approaches to two important challenges in clinical health management: AI-driven care planning and trial-to-patient matching.

At ThinkBio.Ai®, we are focused on developing clinical health solutions from multi-variable, multi-modal data. Addressing complex healthcare challenges requires more than bringing together diverse datasets. It also requires a clear understanding of real-world clinical needs and how AI can effectively support existing healthcare workflows.

Through the Mayo Clinic Platform Accelerate program, ThinkBio.Ai® explored the capabilities of the Mayo Clinic Platform, learned from clinical and healthcare technology experts, and connected with a community focused on advancing healthcare innovation.

As part of this engagement, ThinkBio.Ai® is further exploring how diverse biological and clinical data can be integrated to generate meaningful insights and support more informed, data-driven healthcare.

The experience has provided valuable perspectives as ThinkBio.Ai® continues to develop AI-driven approaches for clinical health management and strengthen its ability to translate complex data into solutions aligned with real-world healthcare needs.

About ThinkBio.Ai®

ThinkBio.Ai® is a knowledge-driven AI company purpose-built to enable biopharma to achieve a faster, shorter development cycle for bringing drugs to market at scale. We address the preclinical and clinical success of drugs by integrating production-ready proprietary multi-scale biomedical knowledge graphs and foundation models to identify hidden biological signals that can help identify at-risk clinical programs early. By shaping the process of early decision-making, we aim to transform the economics of drug development.

Our capabilities extend across complex biological and clinical data, with a focus on developing AI-driven solutions that support drug development and clinical healthcare. Through our platforms and solutions, ThinkBio.Ai® brings together biological knowledge, clinical data, AI/ML, knowledge graphs, and digital twins to generate explainable insights that can support more informed research and healthcare decisions.

Watch the ThinkBio.Ai® Accelerate Cohort Video